Thursday, June 25, 2026

HomeHealth NewsMass spectrometry platform could shrink cancer drug discovery cycle to four hours

Mass spectrometry platform could shrink cancer drug discovery cycle to four hours

- Advertisement -

Purdue researchers Nicolás Morato and R. Graham Cooks’ state-of-the-art mass spectrometry platform enables scientists to generate, analyze and test potential cancer therapies within a single integrated workflow, reducing early-stage drug discovery timelines from weeks to hours. Credit: Purdue University photo/Charles Jischke

Researchers at the Purdue Institute for Cancer Research (PICR) have…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed